We also observed that simvastatin exhibited no significant alteration in intracellular cholesterol levels in TTPAL-knockdown ESCC cells, while also showing no notable impact on the expression of NSUN2 or simvastatin’s target HMGCR (Supplementary Fig. 9B-D). The gene discussed is HMGCR; the disease is esophageal squamous cell carcinoma.